(NASDAQ: TRGT) a clinical-stage biopharmaceutical company advancing NNR Therapeuticsâ„¢ today announced top-line results from a Phase 2b clinical trial of TC-5214 as a treatment for overactive bladder (OAB)
Even the most insightful architecture can prove too inflexible in the face of changing business models, advancing technologies and the volatile fate of companies themselves
advancing הגייה עם משמעויות, מילים נרדפות, הפכים, תרגומים, משפטים ועוד